retatrutide phase 2 obesity nejm 2023 jastreboff GLP-1 Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness Retatrutide UK: How It Works,

That's why these drugs are so effective when it comes to managing type 2 diabetes and weight gain

Patients may experience nausea, vomiting, diarrhea, constipation, or stomach discomfort as the body adjusts to the medication

Patients may notice a loss of vision in one eye upon waking in the morning

Others failed to properly monitor patients for signs of severe gastrointestinal injuries, pancreatitis, or vision loss

31 The second study enrolled 60 patients with varying degrees of renal impairment and administered 5 mg of oral semaglutide daily for the first 5 days, followed by a 10-mg dose once daily for the remaining 5 days of the study

The GLP-1 obesity market, already valued at $8.21 billion in 2025 and projected to reach $66.57 billion by 2035, is the commercial backdrop, but this is still phase 3 data without regulatory submission announced